Company Info
Phone(646) 459-4201
Year Established
2000
Ticker
ATNM
Exchange
NYSE
Contacts
Sandesh SethCEO & Chair
Helen Kotanides, Ph.D.
VP, Translational Research & Preclinical Development
Monideepa Roy, Ph.D.
VP, Corporate Development - R&D
Jenny Hsieh
Chief Strategy Officer
Avinash Desai, M.D.
CMO
Paul Diamond, Ph.D., Esq.
VP, Patent & Legal Counsel
Steve O'Loughlin
CFO
Caroline Yarbrough
CCO
Lynn Bodarky
CBO
Company Description
Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company developing ARCﾒs or Antibody Radiation-Conjugates, which combine the targeting ability of antibodies with the cell killing ability of radiation.
